Vertex Pharmaceuticals Incorporated
Status: Publicly traded
Direct answer
Vertex Pharmaceuticals Incorporated is publicly traded on NASDAQ under the ticker VRTX.
Vertex Pharmaceuticals Incorporated is a leading biotechnology firm primarily focused on the discovery, advancement, and marketing of innovative treatments, particularly for cystic fibrosis (CF). The company offers a range of approved medications for CF patients, including SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO, which target specific mutations within the cystic fibrosis transmembrane conductance regulator gene....
Can you invest in Vertex Pharmaceuticals Incorporated?
Yes. Vertex Pharmaceuticals Incorporated trades publicly on NASDAQ as VRTX.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Vertex Pharmaceuticals Incorporated
Detailed equity research is provided by MarketSnap.